Hims & Hers director buys 48,400 HIMS shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. director David B. Wells reported an open-market purchase of Class A Common Stock. On May 26, 2026, he bought 48,400 shares at an average price of $24.235 per share, increasing his direct holdings to 224,417 shares.
The reported purchase price is a weighted average, with individual trades executed between $24.19 and $24.25 per share. Wells conducted these transactions as direct ownership in the company’s Class A Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Class A Common Stock | 48,400 | $24.235 | $1.17M |
Footnotes (1)
- F1. Price reported constitutes the average weighted price of shares purchased. Shares were purchased at varying prices in the range of $24.19 - $24.25. The Reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Key Figures
Key Terms
open-market purchase financial
Class A Common Stock financial
weighted average price financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did HIMS director David B. Wells report?
Was the HIMS insider purchase by David B. Wells a single trade or multiple trades?
What type of security did David B. Wells acquire in the HIMS Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.